Related references
Note: Only part of the references are listed.Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Mika Shapiro et al.
HAEMATOLOGICA (2017)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Mika Shapiro et al.
HAEMATOLOGICA (2017)
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
Weiling He et al.
CANCER RESEARCH (2017)
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
Yayi He et al.
CANCER SCIENCE (2016)
Relationships between gastrointestinal symptoms, uncertainty, and perceived recovery in patients with gastric cancer after gastrectomy
Byeong Hee Jeon et al.
NURSING & HEALTH SCIENCES (2016)
An increased number of PD-1+and Tim-3+CD8+T cells is involved in immune evasion in gastric cancer
Shuichi Takano et al.
SURGERY TODAY (2016)
Interleukin 10 promotes immune response by increasing the survival of activated CD8+ T cells in human papillomavirus 16-infected cervical cancer
Li Li et al.
TUMOR BIOLOGY (2016)
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
Wei-Wei Deng et al.
ONCOIMMUNOLOGY (2016)
Lymphocyte activation gene 3 and coronary artery disease
Diana Golden et al.
JCI INSIGHT (2016)
LAG3 Expression in Active Mycobacterium tuberculosis Infections
Bonnie L. Phillips et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8+ T Cells That Is Associated with Lower Viral Load
Jose Pena et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
T. Waddell et al.
EJSO (2014)
Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer
Keunwook Lee et al.
GUT AND LIVER (2014)
Targeting CD8+ T-cell tolerance for cancer immunotherapy
Stephanie R. Jackson et al.
IMMUNOTHERAPY (2014)
Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer
Ming Sun et al.
TUMOR BIOLOGY (2014)
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
Chang Song et al.
ONCOIMMUNOLOGY (2014)
Gastric Cancer Epidemiology and Risk Factors
Catherine de Martel et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2013)
Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric Cancer
Bin Deng et al.
PLOS ONE (2013)
Roles of LAG3 and EGR2 in regulatory T cells
Tomohisa Okamura et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Functional heterogeneity of human effector CD8+ T cells
Hiroshi Takata et al.
BLOOD (2012)
Increased tumor-infiltrating CD8+Foxp3+ T lymphocytes are associated with tumor progression in human gastric cancer
Liu-sheng Peng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
Gerritje J. W. van der Windt et al.
IMMUNITY (2012)
ANALYSIS OF CD8+CD28- T-SUPPRESSOR CELLS IN GASTRIC CANCER PATIENTS
Yu Shen et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2012)
Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme
F. Dhalla et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
The CD4-like molecule LAG-3, biology and therapeutic applications
Sophie Sierro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Retrospective analysis of prognostic outcome of gastric cancer in young patients
Rieko Nakamura et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1
Yongyong Shi et al.
NATURE GENETICS (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated lmmunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival
Jana Kotaskova et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Chrystelle Brignone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)